Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IRD | CLLS | ENTA | ||
| Company | Opus Genetics Inc | Cellectis S.A. ADR | Enanta Pharmaceutica | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.89 | 4.11 | 13.59 | ||
| High | 4.94 | 4.15 | 14.00 | ||
| Low | 4.69 | 3.92 | 13.19 | ||
| Latest | 4.80 | 3.92 | 13.41 | ||
| Change | -0.17 | -0.15 | -0.40 | ||
| % Change | -3.42% | -3.69% | -2.90% | ||
| Volume | 917,900 | 37,500 | 221,900 | ||
| 20-Day Average Volume | 996,230 | 21,490 | 184,880 | ||
| Previous Close | 4.97 | 4.07 | 13.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.15 | 3.92 | 14.13 | ||
| 20-Day Raw Stochastic | 13.46% | 46.69% | 19.49% | ||
| 20-Day Relative Strength | 47.25 | 51.60 | 45.34 | ||
| Weighted Alpha | +311.99 | +79.06 | +82.60 | ||
| Today's Opinion | 56% Buy | 32% Buy | 32% Buy | ||
| Previous Opinion | 56% Buy | 56% Buy | 48% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.81% since 05/08/26 | +1.82% since 05/08/26 | -12.58% since 05/08/26 | ||
| Low | 4.69 on 05/15/26 | 3.70 on 05/12/26 | 13.19 on 05/15/26 | ||
| High | 5.23 on 05/11/26 | 4.19 on 05/14/26 | 15.89 on 05/11/26 | ||
| 1-Month | |||||
| %Chg | -15.94% since 04/15/26 | -4.16% since 04/15/26 | -7.84% since 04/15/26 | ||
| Low | 4.66 on 04/29/26 | 3.66 on 05/04/26 | 12.80 on 04/24/26 | ||
| High | 5.81 on 04/17/26 | 4.50 on 04/17/26 | 15.93 on 05/07/26 | ||
| 3-Month | |||||
| %Chg | +31.87% since 02/13/26 | +5.09% since 02/13/26 | -3.18% since 02/13/26 | ||
| Low | 3.29 on 02/23/26 | 2.99 on 03/31/26 | 11.75 on 03/30/26 | ||
| High | 5.81 on 04/17/26 | 4.55 on 04/13/26 | 15.93 on 05/07/26 | ||
| 6-Month | |||||
| %Chg | +155.32% since 11/14/25 | +0.51% since 11/14/25 | +11.19% since 11/14/25 | ||
| Low | 1.70 on 11/18/25 | 2.99 on 03/31/26 | 11.75 on 03/30/26 | ||
| High | 5.81 on 04/17/26 | 5.45 on 12/11/25 | 17.15 on 12/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 390,701 | 393,329 | 389,936 | ||
| Shares Outstanding, K | 81,396 | 100,339 | 29,078 | ||
| Annual Sales | 14,200,000 | 79,590,000 | 65,320,000 | ||
| Annual Net Income | -49,590,000 | -67,590,000 | -81,890,000 | ||
| Last Quarter Sales | 3,870,000 | 12,210,000 | 18,620,000 | ||
| Last Quarter Net Income | -16,520,000 | -26,320,000 | -11,940,000 | ||
| 60-Month Beta | 0.62 | 2.94 | 1.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.75 on 05/12/26 | -0.18 on 05/11/26 | -0.45 on 05/11/26 | ||
| Earnings Date | 08/12/26 | 08/03/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||